跳至主要内容
临床试验/NCT01176825
NCT01176825已完成1 期

Reducing High-Risk Behaviors Among Bipolar Patients Transitioning to Adulthood

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2007年9月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
55
试验地点
2
主要终点
Clinical Global Improvement Scale (CGI)-Improvement

研究概览

简要总结

The aim of the study is to develop and pilot test a cognitive-behavioral (CBT) intervention for young adults, ages 18-24 with bipolar disorder. The 14-week intervention focuses on improving management of bipolar disorder, reducing involvement in high-risk behaviors, and enhancing psychosocial functioning. The intervention also focuses on issues specific to transition-age youth. The study includes two phases: In phase 1, the intervention will be developed, refined, and openly piloted with several participants. In phase 2,the investigators will conduct a randomized clinical trial, in which 40 participants will be randomized either to receive the intervention right away, or to a 14-week waitlist condition. Participants will be evaluated at baseline, week 5, week 10, and week 14 of the study period, as well as at 3- and 6-month follow up, using measures of mood symptoms, high-risk behaviors, drug and alcohol use, and psychosocial functioning.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 24 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of bipolar spectrum disorder (Bipolar I, Bipolar II, or Bipolar NOS Disorder)
  • ages 18-24 years
  • able to understand the nature of the study as well as potential risks and benefits
  • in treatment with a physician or nurse-practitioner for their bipolar disorder, or willing to seek and obtain such treatment if needed.

排除标准

  • concurrent cognitive-behavioral psychotherapy
  • documented mental retardation
  • pervasive developmental disorder
  • current serious medical illness
  • inability to participate in the intervention because of acuity of symptoms
  • current drug or alcohol dependence (other than marijuana dependence)

结局指标

主要结局

Clinical Global Improvement Scale (CGI)-Improvement

时间窗: week 5, week 10, week 14, 3 mo fu, 6 mo fu

Clinician-rated change in mood symptoms and overall functioning

feasibility and acceptability

时间窗: post-treatment

We will assess the percentage of completers versus drop-outs to examine feasibility of treatment procedures

次要结局

  • Self-Control Behavior Schedule(baseline, week 5, week 10, week 14, 3 mo fu, 6 mo fu)
  • Adapted Y-BOCS(baseline, week 5, week 10, week 14, 3 mo fu, 6 mo fu)
  • Timeline Follow-Back(baseline, week 5, week 10, week 14, 3 mo fu, 6 mo fu)
  • Medication history and adherence(baseline, post-treatment, 6 month follow-up)
  • High-Risk Sexual Behaviors(baseline, week 5, week 10, week 14, 3 mo fu, 6 mo fu)
  • Beck Hopelessness Scale(baseline, week 5, week 10, week 14, 3 mo fu, 6 mo fu)
  • Social Adjustment Scale (SAS)(baseline, week 5, week 10, week 14, 3 mo fu, 6 mo fu)
  • Barratt Impulsiveness Scale(baseline, week 5, week 10, week 14, 3 mo fu, 6 mo fu)
  • Young Mania Rating Scale(baseline, week 5, week 10, week 14, 3 mo fu, 6 mo fu)
  • SCID depression and mania modules(baseline, week 5, week 10, week 14, 3 mo fu, 6 mo fu)
  • Adult Suicidal Ideation Questionnaire (ASIQ)(baseline, week 5, week 10, week 14, 3 mo fu, 6 mo fu)
  • Hamilton Depression Scale (HAM-D)(baseline, week 5, week 10, week 14, 3 mo fu, 6 mo fu)
  • Risky Driving Inventory(baseline, week 5, week 10, week 14, 3 mo fu, 6 mo fu)
  • Treatment Satisfaction Questionnaire(post-treatment)
  • South Oaks Gambling Screen(baseline, week 5, week 10, week 14, 3 mo fu, 6 mo fu)
  • Urine Toxicology Screen(baseline, post-treatment, 6 mo follow-up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Aude Henin

Co-Director, Child CBT Program

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验

Cognitive-Behavior Therapy for Young Adults With... | 临床试验